Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email | Twitter) and we will feature it here each Friday.
Siemens CEO Peter Löscher ousted amid revenue struggle
Siemens ($SI) pulled the plug on CEO Peter Löscher as the company revealed a reorganization of this year's fiscal goals. The German healthcare med tech business said it no longer expects to meet the 12% profit margin it initially proclaimed for fiscal 2013, leading to a 7% drop in shares. Löscher's spot at the top will go to Joe Kaeser, Siemens' former CFO, who will now be expected to mop up the struggling revenue base. Story
|
Biotech
> Moderna Therapeutics brought on Joseph Bolen as the company's president of research and development. Bolen, the former chief scientific officer and global head of oncology research at Millennium, began his career at the National Institutes of Health. Release
> Advanced Prenatal Therapeutics has appointed its first scientific adviser, Dr. Nihar Nayak. Nayak is an associate professor of Obstetrics and Gynecology and the director of Translational Research in the Division of Maternal-Fetal Medicine at Stanford University School of Medicine. Release
> Clinverse has hired Bud Owen as chief financial officer and Tony Click as chief technology officer. Release
> Genesis Biopharma has appointed Sanford J. Hillsberg and Dr. Jay Venkatesan to its board of directors. Genesis also announced that Paul Kessler and David Voyticky have turned in their resignations as directors. Release
> Dr. Raymond L. Woosley has been appointed to ARCA biopharma's ($ABIO) board of directors. Woosley is the president and chairman of the board of the Arizona Center for Education and Research on Therapeutics. Release
> Gil Yosipovitch and Praveen Anand joined the scientific advisory board at Creabilis. Article
> Insmed ($INSM) appointed Christine Pellizzari as general counsel and corporate secretary. Pellizzari was most recently executive vice president, general counsel and corporate secretary at Aegerion Pharmaceuticals ($AEGR). Release
> Chris Gowland joined Aesica as the company's newly added chief operating officer. Release
Pharma
> Two new members have been appointed to Sanofi's ($SNY) executive committee. Carsten Hellmann joins Sanofi from Chr. Hansen Holding A/S and will take the position of executive vice president of Merial, the company's animal health division, replacing Jose Barella. Dr. David Meeker, currently CEO of Genzyme and a member of the Global Leadership Team, will join the executive committee as executive vice president, Genzyme. Release
> Robert P. Roche Jr. has joined Antares Pharma's ($ATRS) board of directors. Roche previously led commercial operations at Cephalon and was executive vice president at Worldwide Pharmaceutical Operations. Release
Medical Devices
> Horizon Discovery has appointed Dr. Ian Gilham to its board of directors. Gilham has previously been CEO of Axis-Shield plc and vice president, Pharmacogenetics and Diagnostics at GlaxoSmithKline ($GSK). Release
CRO
> Advanced Clinical has added Cheryle Evans to its leadership team as vice president, Clinical Operations. Prior to joining Advanced, Evans served as vice president, Clinical Operations for North America with a top 5 CRO. Release